The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Self-citationDifferential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72307-0 · Cited by 1,282
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,208
Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Self-citationHall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).
Sporn, M. B., Dunlop, N. M., Newton, D. L., & Smith, J. M. (1976) · PubMed · Cited by 992
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., & Nakshatri, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010840200 · Cited by 968
Overview of the main outcomes in breast-cancer prevention trials
Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 965
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
The nuclear receptor ligand-binding domain: structure and function
Moras, D., & Gronemeyer, H. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80015-x · Cited by 843
Cummings, S. R. (1999) · Medical Entomology and Zoology · Cited by 797
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, H. M., & Osborne, C. K. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01961241 · Cited by 750
Schwabe, J. W. R., Chapman, L., Finch, J. T., & Rhodes, D. (1993) · Cell · doi:10.1016/0092-8674(93)90390-c · Cited by 750
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.
Henderson, B. E., Ross, R. K., & Bernstein, L. (1988) · PubMed · Cited by 700
Cauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Self-citationThe role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
Key, T. J. A., & Pike, M. C. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90173-3 · Cited by 651
Gordon, D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92329-1 · Cited by 552
Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies
Rutqvist, L. E., Johansson, H., Signomklao, T., Johansson, U., Fornander, T., & Wilking, N. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.645 · Cited by 508
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
Clarke, R., Liu, M. C., Bouker, K. B., Gu, Z., Lee, R. Y., Zhu, Y., Skaar, T. C., Gomez, B., O'Brien, K., Wang, Y., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206937 · Cited by 478
Biologic and therapeutic role of HER2 in cancer
Ménard, S., Pupa, S. M., Campiglio, M., & Tagliabue, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206779 · Cited by 432
Howell, A., Robertson, J. F. R., Abram, P., Lichinitser, M. R., Elledge, R., Bajetta, E., Watanabe, T., Morris, C., Webster, A., Dimery, I., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.112 · Cited by 421
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
Paige, L. A., Christensen, D. J., Grøn, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C.-Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3999 · Cited by 412
Song, R. X.-D., McPherson, R. A., Adam, L., Bao, Y., Shupnik, M., Kumar, R., & Santen, R. J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.1.0748 · Cited by 407
Saville, B., Wormke, M., Wang, F., Nguyen, T., Enmark, E., Kuiper, G., Gustafsson, J.-Å., & Safe, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5379 · Cited by 401
Jordan, V. C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020450x · Cited by 396
Self-citationOestrogen receptors – an overview
Enmark, E., & Gustafsson, J. ‐. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00545.x · Cited by 380
Estrogen receptor β acts as a dominant regulator of estrogen signaling
Pettersson, K., Delaunay, F., & Gustafsson, J.-Å. (2000) · Oncogene · doi:10.1038/sj.onc.1203828 · Cited by 362
Gottardis, M. M., & Jordan, V. C. (1987) · PubMed · Cited by 352
Self-citationStructural Insights into the Mode of Action of a Pure Antiestrogen
Pike, A. C. W., Brzozowski, A. M., Walton, J., Hubbard, R. E., Thorsell, A.-G., Li, Y.-L., Gustafsson, J.-Å., & Carlquist, M. (2001) · Structure · doi:10.1016/s0969-2126(01)00568-8 · Cited by 347
Role of Hormones in Mammary Cancer Initiation and Progression
Russo, I. H., & Russo, J. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018770218022 · Cited by 337
Selective estrogen receptor modulation
Jordan, V. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00059-5 · Cited by 315
Self-citationThe biological role of estrogen receptors α and β in cancer
Pearce, S. T., & Jordan, V. C. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.003 · Cited by 311
Self-citationSchiff, R., Massarweh, S. A., Shou, J., & Osborne, C. K. (2003) · PubMed · Cited by 304
Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.
Greaves, P., Goonetilleke, R., Nunn, G., Topham, J. C., & Orton, T. C. (1993) · PubMed · Cited by 298
Song, R. X.-D., Mor, G., Naftolin, F., McPherson, R. A., Song, J., Zhang, Z., Yue, W., Wang, J., & Santen, R. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1714 · Cited by 293
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
Russo, J., Hasan Lareef, M., Balogh, G., Guo, S., & Russo, I. H. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00390-x · Cited by 252
Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208133270706 · Cited by 247
Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.
Jj, L., & Li, S. A. (1987) · PubMed · Cited by 243
Yue, W., Santen, R. J., Wang, J.-P., Li, Y., Verderame, M. F., Bocchinfuso, W. P., Korach, K. S., Devanesan, P., Todorovic, R., Rogan, E. G., et al. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00377-7 · Cited by 238
Lønning, P. E., Taylor, P. D., Anker, G., Iddon, J., Wie, L., Jørgensen, L.-M., Mella, O., & Howell, A. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010619225209 · Cited by 226
Hall, J. M. (1999) · Endocrinology · doi:10.1210/en.140.12.5566 · Cited by 226
Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
Dorgan, J. F., Longcope, C., Stephenson, H. E., Falk, R. T., Miller, R., Franz, C., Kahle, L., Campbell, W. S., Tangrea, J. A., & Schatzkin, A. G. (1996) · PubMed · Cited by 219
Jordan, V. C., & Allen (née Naylor), K. E. (1980) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(80)90156-5 · Cited by 214
Self-citationEstrogens in the Nervous System: Mechanisms and Nonreproductive Functions
Maggi, A., Ciana, P., Belcredito, S., & Vegeto, E. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032802.154945 · Cited by 211
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
Shao, W., & Brown, M. (2003) · Breast Cancer Research · doi:10.1186/bcr742 · Cited by 203
Clemens, J. A., Bennett, D. R., Black, L. J., & Jones, C. D. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90323-5 · Cited by 176
Howell, S. J., Johnston, S. R. D., & Howell, A. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2003.08.002 · Cited by 159
Johnston, S. R. D., Head, J. E., Pancholi, S., DETRE, S. I., Martin, L., Smith, I. E., & Dowsett, M. (2003) · PubMed · Cited by 152
Dysregulation of cellular signaling by HER2 in breast cancer
Zhou, B. P., & Hung, M.-C. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.006 · Cited by 149
Willson, T. M., Henke, B. R., Momtahen, T. M., Charifson, P. S., Batchelor, K. W., Lubahn, D. B., Moore, L. B., Oliver, B. B., Sauls, H. R., Triantafillou, J. A., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00037a002 · Cited by 146
Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo
Liu, H., Lee, E.-S., Gajdos, C., Pearce, S. T., Chen, B., Osipo, C., Loweth, J., McKian, K., Reyes, A. D. L., Wing, L., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg080 · Cited by 146
Self-citationOsborne, C. K., & Schiff, R. (2003) · The Breast · doi:10.1016/s0960-9776(03)00137-1 · Cited by 146
Dittmar, T., Husemann, A., Schewe, Y., Nofer, J., Niggemann, B., Zänker, K. S., & Brandt, B. (2002) · The FASEB Journal · doi:10.1096/fj.02-0096fje · Cited by 137
LY353381.HCl: A Novel Raloxifene Analog with Improved SERM Potency and Efficacy In Vivo
Sato, M., Turner, C. H., Wang, T., Adrian, M. D., Rowley, E. R., & Bryant, H. U. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37755-9 · Cited by 136
Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.
Hemminki, K., Rajaniemi, H. J., Lindahl, B., & Moberger, B. (1996) · PubMed · Cited by 135
Suppression of Mouse Mammary Tumorigenesis by Long-Term Tamoxifen Therapy
Jordan, V. C., Lababidi, M. K., & Langan-Fahey, S. M. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.7.492 · Cited by 134
Self-citationOsipo, C., Gajdos, C., Liu, H., Chen, B., & Jordan, V. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg079 · Cited by 131
Self-citationUnderstanding the genotoxicity of tamoxifen?
Phillips, D. H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.6.839 · Cited by 125
Song, R. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.116 · Cited by 125
Gender‐Specific Regulation of Cardiovascular Function: Estrogen as Key Player
Huang, A., & Kaley, G. (2004) · Microcirculation · doi:10.1080/10739680490266162 · Cited by 118
Schafer, J. M., Liu, H., Bentrem, D. J., Zapf, J. W., & Jordan, V. C. (2000) · PubMed · Cited by 109
Self-citationSuh, N., Glasebrook, A. L., Palkowitz, A. D., Bryant, H. U., Burris, L. L., Starling, J. J., Pearce, H. L., Williams, C. R., Peer, C. W., Wang, Y., et al. (2001) · PubMed · Cited by 104
Waterman, H., Alroy, I., Strano, S., Seger, R., & Yarden, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3348 · Cited by 103
Glatt, H. R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.10.1709 · Cited by 92
Lonard, D. M., Tsai, S. Y., & O’Malley, B. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.14-24.2004 · Cited by 85
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., & Wolmark, N. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.020 · Cited by 82
Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice
Wolf, D. M., & Jordan, V. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00689682 · Cited by 78
Self-citationCharacterization of membrane estrogen binding proteins from rabbit uterus
Monje, P. V., & Boland, R. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00212-3 · Cited by 70
Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat
Martel, C., Picard, S., Richard, V., Bélanger, A., Labrie, C., & Labrie, F. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00087-x · Cited by 57
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models.
Brady, H. A., Desai, S. J., Gayo, L. M., Khammungkhune, S., McKie, J. A., O'Leary, E. C., Pascasio, L., Sutherland, M. K., Anderson, D. W., Bhagwat, S. S., et al. (2002) · PubMed · Cited by 49
Fulvestrant and the sequential endocrine cascade for advanced breast cancer
Johnston, S. R. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601632 · Cited by 47
Sato, M., Zeng, G. Q., Rowley, E. R., & Turner, C. H. (1998) · Endocrinology · doi:10.1210/endo.139.11.6307 · Cited by 46
Li, Y., Bryant, H. U., Zeng, Q., Palkowitz, A. D., Jee, W. S. S., Turner, C. H., & Sato, M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2256 · Cited by 46
Rationale and Overview of the Raloxifene Use for the Heart (RUTH) Trial
Mosca, L. J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04018.x · Cited by 31
Sato, M. (1998) · Endocrinology · doi:10.1210/en.139.11.4642 · Cited by 15
Castro‐Rivera, E., & Safe, S. H. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00010-4 · Cited by 13
Cited by
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Deeb, K. K., Trump, D. L., & Johnson, C. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2196 · Cited by 1,419
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Miller, T. E., Ghoshal, K., Ramaswamy, B., Roy, S., Datta, J., Shapiro, C. L., Jacob, S., & Majumder, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804612200 · Cited by 749
Metadata
- Authors
- Lewis, J. S., & Jordan, V. C.
- Venue
- Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 591
- Issue
- 1-2
- Pages
- 247-263
- ISSN
- 0027-5107 (ISSN-L)
- 1386-1964
- OpenAlex
- W2094161819
- Cited by
- 281
- References
- 96
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.